H. Bachelez

2.5k total citations · 2 hit papers
41 papers, 1.4k citations indexed

About

H. Bachelez is a scholar working on Immunology, Dermatology and Physiology. According to data from OpenAlex, H. Bachelez has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 23 papers in Dermatology and 8 papers in Physiology. Recurrent topics in H. Bachelez's work include Psoriasis: Treatment and Pathogenesis (32 papers), Dermatology and Skin Diseases (17 papers) and Asthma and respiratory diseases (7 papers). H. Bachelez is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (32 papers), Dermatology and Skin Diseases (17 papers) and Asthma and respiratory diseases (7 papers). H. Bachelez collaborates with scholars based in France, United States and Germany. H. Bachelez's co-authors include Mark Lebwohl, L. Puig, A. David Burden, Kenneth B. Gordon, Kim Papp, Andrew Blauvelt, Bruce Strober, Mary Flack, Yves Poulin and Matthias Augustin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

H. Bachelez

38 papers receiving 1.4k citations

Hit Papers

Efficacy and safety of risankizumab in moderate-to-severe... 2018 2026 2020 2023 2018 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
    2018 452 citations Kenneth B. Gordon, Bruce Strober et al. profile →
  2. Trial of Spesolimab for Generalized Pustular Psoriasis
    2021 194 citations H. Bachelez, Siew Eng Choon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Bachelez France 16 1.2k 822 300 270 209 41 1.4k
Mary Flack United States 11 1.3k 1.1× 822 1.0× 311 1.0× 200 0.7× 194 0.9× 25 1.5k
Isabelle Hampele United States 6 1.3k 1.1× 751 0.9× 256 0.9× 261 1.0× 344 1.6× 8 1.6k
Thomas Salko United States 5 1.3k 1.0× 720 0.9× 253 0.8× 244 0.9× 333 1.6× 5 1.6k
Ming-Chun Hsu United States 9 1.5k 1.3× 824 1.0× 270 0.9× 281 1.0× 323 1.5× 14 1.7k
Yin You United States 17 1.0k 0.8× 478 0.6× 130 0.4× 132 0.5× 341 1.6× 34 1.2k
Gregory Kricorian United States 14 1.4k 1.1× 718 0.9× 278 0.9× 200 0.7× 387 1.9× 23 1.7k
J.M.P.A. van den Reek Netherlands 20 785 0.6× 470 0.6× 186 0.6× 98 0.4× 217 1.0× 41 1.1k
Talia M. Muram United States 11 775 0.6× 426 0.5× 175 0.6× 133 0.5× 206 1.0× 18 972
Michael Song United States 22 2.1k 1.7× 1.3k 1.5× 450 1.5× 298 1.1× 682 3.3× 49 2.5k
Kavitha Goyal United States 12 828 0.7× 389 0.5× 101 0.3× 130 0.5× 204 1.0× 22 1.0k

Countries citing papers authored by H. Bachelez

Since Specialization
Citations

This map shows the geographic impact of H. Bachelez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bachelez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bachelez more than expected).

Fields of papers citing papers by H. Bachelez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bachelez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bachelez. The network helps show where H. Bachelez may publish in the future.

Co-authorship network of co-authors of H. Bachelez

This figure shows the co-authorship network connecting the top 25 collaborators of H. Bachelez. A scholar is included among the top collaborators of H. Bachelez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Bachelez. H. Bachelez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuxuan, Zhiwei Wang, Xiaochen Dai, et al.. (2025). Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis. Journal of Investigative Dermatology. 146(4). 1034–1045.e22.
2.
Viguier, M., Malek Bentayeb, Gérard de Pouvourville, et al.. (2024). Generalized pustular psoriasis: A nationwide population‐based study using the National Health Data System in France. Journal of the European Academy of Dermatology and Venereology. 38(6). 1131–1139. 9 indexed citations
3.
Visvanathan, Sudha, H. Bachelez, Akimichi Morita, et al.. (2024). Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1. Journal of Investigative Dermatology. 145(3). 573–582.e8. 2 indexed citations
4.
Burden, A. David, H. Bachelez, Siew Eng Choon, et al.. (2023). The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity. British Journal of Dermatology. 189(1). 138–140. 8 indexed citations
5.
Burden, A. David, Robert Bissonnette, Mark Lebwohl, et al.. (2023). Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI). Journal of the European Academy of Dermatology and Venereology. 37(7). 1327–1335. 14 indexed citations
6.
Bouaziz, Jean‐David, M. Jachiet, F. Cordoliani, et al.. (2023). Serum infliximab levels and clinical response in hidradenitis suppurativa. SHILAP Revista de lepidopterología. 2(2). 306–312. 2 indexed citations
7.
Bachelez, H., Juliet N. Barker, A. David Burden, Alexander A. Navarini, & James G. Krueger. (2022). Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Review of Clinical Immunology. 18(10). 1033–1047. 41 indexed citations
8.
Bachelez, H., et al.. (2022). 479 Distinct patterns of gene expression in skin biopsies differentiate generalized pustular psoriasis (GPP) from psoriasis vulgaris (PV). Journal of Investigative Dermatology. 142(8). S81–S81. 1 indexed citations
9.
Morita, Akimichi, Siew Eng Choon, H. Bachelez, et al.. (2022). Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis. Dermatology and Therapy. 13(1). 347–359. 25 indexed citations
10.
Penso, Laëtitia, Viet-Thi Tran, Claire Hotz, et al.. (2021). Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts. Dermatology. 237(5). 748–758. 5 indexed citations
11.
Gordon, Kenneth B., Mark Lebwohl, Kim Papp, et al.. (2021). Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*. British Journal of Dermatology. 186(3). 466–475. 69 indexed citations
12.
Baum, Patrick, Sudha Visvanathan, Sandra Garcet, et al.. (2021). Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis. Journal of Allergy and Clinical Immunology. 149(4). 1402–1412. 52 indexed citations
13.
14.
Duffin, Kristina Callis, H. Bachelez, Philip J. Mease, et al.. (2021). Pustular Psoriasis and Associated Musculoskeletal Disorders. The Journal of Rheumatology. 97. jrheum.201673–jrheum.201673. 4 indexed citations
15.
Enk, Alexander & H. Bachelez. (2020). ESDR Academy for Future Leaders in Dermatology: A Modern Success Story to Foster Young Academic Dermatologists and Skin Scientists. Journal of Investigative Dermatology. 140(9). S183–S184.
16.
Bachelez, H.. (2020). Pustular Psoriasis: The Dawn of a New Era. Acta Dermato Venereologica. 100(3). 87–93. 69 indexed citations
17.
18.
19.
Gordon, Kenneth B., Bruce Strober, Mark Lebwohl, et al.. (2018). EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS. 98. 10 indexed citations
20.
Langley, Richard G., Ricardo Romiti, Kristian Reich, et al.. (2016). 053 Evaluation of inflammatory bowel disease in patients with plaque psoriasis studied in phase 3 trials of ixekizumab (UNCOVER Trials): Adjudicated data from the induction period. Journal of Investigative Dermatology. 136(9). S169–S169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Flack Breakdown of academic impact, for papers by Isabelle Hampele Breakdown of academic impact, for papers by Thomas Salko Breakdown of academic impact, for papers by Ming-Chun Hsu Breakdown of academic impact, for papers by Yin You Breakdown of academic impact, for papers by Gregory Kricorian Breakdown of academic impact, for papers by J.M.P.A. van den Reek Breakdown of academic impact, for papers by Talia M. Muram Breakdown of academic impact, for papers by Michael Song Breakdown of academic impact, for papers by Kavitha Goyal
Rankless by CCL
2026